CoQ10, a vitamin-like dietary supplement the body also makes for cellular energy, is used for healthy aging; levels fall with age and with cholesterol-lowering drugs. Support is strongest in heart failure, with fewer hospital stays; smaller benefits appear for blood pressure, fatigue and migraine. Healthy, fit older adults gained no muscle energy. Side effects are mostly mild stomach upset; the main concern is unstable clotting control in warfarin users. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Plasma total CoQ10 | Above 2.5 µg/mL in advanced heart failure | Confirms absorption |
| INR (warfarin users) | 0.8–1.2 (standard reference range); warfarin users tracked against their prescribed therapeutic range | Safety check; a shift changes use |
| Blood pressure | No established target for CoQ10 use; tracked as change from own baseline | Expected to fall slightly; safety check with antihypertensives |
| LDL-C and triglycerides | No established target for CoQ10 use; tracked as change from own baseline | Expected to change slightly |
| HbA1c and fasting glucose (diabetes) | HbA1c 4.0–5.6%; fasting glucose 70–99 mg/dL (standard reference range) | Expected to fall slightly; safety check on glucose-lowering drugs |
Cadence: Baseline before starting; INR at one to two weeks for warfarin users; blood pressure weekly for the first month; plasma CoQ10 at 4–8 weeks; lipids and glucose markers at 3 months; then every 6–12 months while use continues